Sanofi (SNY) Gross Profit (2009 - 2026)

Sanofi (SNY) has 18 years of Gross Profit data on file, last reported at $9.5 billion in Q1 2026.

• Quarterly Gross Profit rose 16.91% year-over-year to $9.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.6 billion (up 24.49% YoY) and the FY2025 annual result came in at $39.2 billion, up 18.0% from the prior year.
• Gross Profit improved to $9.5 billion in Q1 2026 per SNY's latest filing, from -$8.2 billion in the prior quarter.
• The five-year high for Gross Profit was $34.7 billion in Q4 2023, with the low at -$8.2 billion in Q4 2025.
• Average Gross Profit over 5 years is $10.2 billion, with a median of $8.1 billion recorded in 2025.
• Year-over-year, Gross Profit soared 339.86% in 2023 and plunged 242.49% in 2025.
• Sanofi's Gross Profit stood at $7.9 billion in 2022, then soared by 339.86% to $34.7 billion in 2023, then tumbled by 83.47% to $5.7 billion in 2024, then sank by 242.49% to -$8.2 billion in 2025, then surged by 216.28% to $9.5 billion in 2026.
• Business Quant data shows SNY's Gross Profit at $9.5 billion in Q1 2026, -$8.2 billion in Q4 2025, and $29.5 billion in Q3 2025.